These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16562600)

  • 21. Obesity, proteinuria and progression of renal failure.
    Praga M; Morales E
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):481-6. PubMed ID: 16914959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.
    Xu T; Sheng Z; Yao L
    Front Med; 2017 Sep; 11(3):340-348. PubMed ID: 28791668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of proteinuric renal disease and the emerging role of endothelin.
    Barton M
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, inflammation, and macrophages.
    Subramanian V; Ferrante AW
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():151-9; discussion 159-62, 259-68. PubMed ID: 19346774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
    Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of obesity with inflammation in occult chronic kidney disease.
    Bavbek N; Isik B; Kargili A; Uz E; Uz B; Kanbay M; Turgut F; Karakurt F; Akcay A
    J Nephrol; 2008; 21(5):761-7. PubMed ID: 18949732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Obesity influence on renal function].
    Sudoł A; Wnuk RS; Duława J
    Pol Merkur Lekarski; 2006 Apr; 20(118):490-3. PubMed ID: 16886583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A big boy with proteinuria. Focal and segmental glomerulosclerosis.
    Quinlan C; Dorman T; Gill D
    Pediatr Nephrol; 2008 Dec; 23(12):2175-8. PubMed ID: 18704510
    [No Abstract]   [Full Text] [Related]  

  • 31. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity-related glomerulopathy in China: a case series of 90 patients.
    Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
    Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor.
    Dobrian AD
    Vascul Pharmacol; 2006 Jul; 45(1):36-45. PubMed ID: 16716756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study.
    Ferris M; Hogan SL; Chin H; Shoham DA; Gipson DS; Gibson K; Yilmaz S; Falk RJ; Jennette JC
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1207-14. PubMed ID: 17942783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excess weight as a risk factor for kidney failure.
    Nguyen S; Hsu CY
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):71-6. PubMed ID: 17293680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
    Agarwal R
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1523-8. PubMed ID: 19478099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between body fat distribution and renal damage in Chinese with obesity.
    Chen H; Liu Z; Li S; Chen Y; Yang B; Cai J; Wang Q; Li L
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):99-103. PubMed ID: 18095240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
    Windt WA; Tahara A; Kluppel AC; de Zeeuw D; Henning RH; van Dokkum RP
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.